Mirae Asset Global Investments Co., Ltd. Rocket Pharmaceuticals, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$37.3 Billion
Q1 2025

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,568 shares of RCKT stock, worth $9,883. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,568

Previous 3,038 17.45%

Holding current value

$9,883

Previous $38,000 39.47%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	BUY	$6.67 - $12.72 $3,535 - $6,741	530 Added 17.45%	3,568 $23,000
Q4 2024 Jan 27, 2025	SELL	$11.35 - $18.82 $2,882 - $4,780	-254 Reduced 7.72%	3,038 $38,000
Q3 2024 Oct 23, 2024	BUY	$17.6 - $25.88 $10,243 - $15,062	582 Added 21.48%	3,292 $60,000
Q2 2024 Jul 30, 2024	SELL	$20.66 - $26.72 $6.18 Million - $7.99 Million	-299,122 Reduced 99.1%	2,710 $58,000
Q1 2024 May 01, 2024	BUY	$26.16 - $30.74 $3.38 Million - $3.98 Million	129,358 Added 75.0%	301,832 $8.13 Million
Q4 2023 Jan 24, 2024	SELL	$16.78 - $31.94 $3.61 Million - $6.87 Million	-215,230 Reduced 55.51%	172,474 $5.17 Million
Q3 2023 Oct 26, 2023	BUY	$15.07 - $24.05 $477,010 - $761,254	31,653 Added 8.89%	387,704 $7.94 Million
Q2 2023 Aug 10, 2023	BUY	$16.59 - $23.6 $854,949 - $1.22 Million	51,534 Added 16.92%	356,051 $7.07 Million
Q1 2023 May 04, 2023	BUY	$15.79 - $22.6 $317,126 - $453,898	20,084 Added 7.06%	304,517 $5.22 Million
Q4 2022 Feb 09, 2023	SELL	$15.5 - $22.76 $882,926 - $1.3 Million	-56,963 Reduced 16.69%	284,433 $5.57 Million
Q3 2022 Nov 10, 2022	BUY	$12.37 - $18.41 $969,758 - $1.44 Million	78,396 Added 29.81%	341,396 $5.45 Million
Q2 2022 Jul 26, 2022	BUY	$7.96 - $16.64 $173,591 - $362,885	21,808 Added 9.04%	263,000 $3.62 Million
Q1 2022 May 10, 2022	SELL	$13.16 - $23.68 $410,749 - $739,100	-31,212 Reduced 11.46%	241,192 $3.83 Million
Q4 2021 Feb 08, 2022	BUY	$21.52 - $36.02 $1.35 Million - $2.27 Million	62,896 Added 30.02%	272,404 $5.95 Million
Q3 2021 Nov 15, 2021	BUY	$27.42 - $48.97 $1.2 Million - $2.15 Million	43,930 Added 26.53%	209,508 $6.26 Million
Q2 2021 Aug 11, 2021	BUY	$39.41 - $47.25 $1.16 Million - $1.39 Million	29,500 Added 21.68%	165,578 $7.33 Million
Q1 2021 May 13, 2021	BUY	$43.34 - $65.91 $3.17 Million - $4.82 Million	73,124 Added 116.15%	136,078 $6.04 Million
Q4 2020 Feb 10, 2021	BUY	$23.3 - $59.57 $323,963 - $828,261	13,904 Added 28.35%	62,954 $3.45 Million
Q3 2020 Nov 12, 2020	BUY	$20.5 - $28.59 $324,392 - $452,408	15,824 Added 47.63%	49,050 $1.12 Million
Q2 2020 Aug 11, 2020	BUY	$13.32 - $22.61 $181,032 - $307,292	13,591 Added 69.22%	33,226 $696,000
Q1 2020 May 12, 2020	BUY	$9.71 - $25.11 $20,847 - $53,911	2,147 Added 12.28%	19,635 $274,000
Q4 2019 Feb 12, 2020	BUY	$11.07 - $24.23 $36,464 - $79,813	3,294 Added 23.21%	17,488 $398,000
Q3 2019 Nov 12, 2019	BUY	$10.85 - $14.78 $154,004 - $209,787	14,194 New	14,194 $165,000

Others Institutions Holding RCKT

# of Institutions

258

Shares Held

108M

Call Options Held

555K

Put Options Held

177K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $210M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Rocket Pharmaceuticals, Inc. Transaction History